We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$976M
Turnover
59%
1-Year Est. Return
66.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.98%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$870M
AUM Growth
+$47.6M
(+5.8%)
Cap. Flow
+$72.9M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
41.99%
Holding
97
New
35
Increased
13
Reduced
14
Closed
20
Avg Time Held Equity + Options
0.6
years
Top 10 Avg Time Held Equity + Options
0.5
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
0.8
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RenaissanceRe
RNR
|
+$27.4M |
| 2 |
Palo Alto Networks
PANW
|
+$20.2M |
| 3 |
Arch Capital
ACGL
|
+$17M |
| 4 |
United Rentals
URI
|
+$16.1M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lithia Motors
LAD
|
+$24.9M |
| 2 |
Shift4
FOUR
|
+$18M |
| 3 |
Bread Financial
BFH
|
+$13.1M |
| 4 |
PagSeguro Digital
PAGS
|
+$12.6M |
| 5 |
Generac Holdings
GNRC
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.5% |
| 2 | Miscellaneous | 23.2% |
| 3 | Financials | 12.16% |
| 4 | Industrials | 8.68% |
| 5 | Consumer Discretionary | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
Invesco QQQ Trust
QQQ
$487B
| $74.9M | 8.61% |
+188,200
| New | +$72.7M |
2021 Q4
0 quarters
|
|
2
Meta Platforms (Facebook)
META
$1.88T
| $51.7M | 5.94% |
153,605
+30,038
| +24% | +$9.97M |
2019 Q3
9 quarters
|
|
3
DELISTED
RAPT Therapeutics
RAPT
| $42.2M | 4.85% |
143,540
| – | – |
2020 Q4
4 quarters
|
|
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $41.4M | 4.76% |
300,373
-65,000
| -18% | -$8.27M |
2018 Q1
15 quarters
|
|
|
5
RenaissanceRe
RNR
$14.3B
| $29.6M | 3.41% |
+175,000
| New | +$27.4M |
2021 Q4
0 quarters
|
|
|
6
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $27.6M | 3.17% |
+200,000
| New | +$25.4M |
2021 Q4
0 quarters
|
|
7
Humana
HUM
$51.9B
| $26.5M | 3.04% |
57,029
+23,229
| +69% | +$10.3M |
2021 Q3
1 quarter
|
|
8
APi Group
APG
$17.4B
| $26.3M | 3.02% |
1,530,192
-513,792
| -25% | -$7.89M |
2020 Q2
6 quarters
|
|
9
Tandem Diabetes Care
TNDM
$1.15B
| $22.6M | 2.6% |
150,000
+39,000
| +35% | +$5.26M |
2021 Q3
1 quarter
|
|
10
CALL
Biogen
BIIB
$34.8B
| $22.6M | 2.59% |
+94,000
| New | +$24.2M |
2021 Q4
0 quarters
|
|
|
11
Palo Alto Networks
PANW
$303B
| $21.7M | 2.49% |
+233,400
| New | +$20.2M |
2021 Q4
0 quarters
|
|
12
Avery Dennison
AVY
$13.3B
| $21.2M | 2.44% |
97,847
+18,197
| +23% | +$3.89M |
2021 Q3
1 quarter
|
|
13
Amazon
AMZN
$2.75T
| $21M | 2.41% |
125,740
+35,120
| +39% | +$6.01M |
2021 Q1
3 quarters
|
|
14
PUT
iShares Russell 2000 ETF
IWM
$77.5B
| $19.4M | 2.23% |
87,000
-348,000
| -80% | -$78.6M |
2021 Q3
1 quarter
|
|
|
15
Arch Capital
ACGL
$33.9B
| $17.8M | 2.04% |
+400,000
| New | +$17M |
2021 Q4
0 quarters
|
|
|
SBNY
16
DELISTED
Signature Bank
SBNY
| $17.5M | 2.01% |
54,065
-1,685
| -3% | -$525K |
2021 Q2
2 quarters
|
|
|
17
Vertex Pharmaceuticals
VRTX
$129B
| $17M | 1.95% |
+77,300
| New | +$15M |
2021 Q4
0 quarters
|
|
|
18
United Rentals
URI
$65.2B
| $15M | 1.72% |
+45,117
| New | +$16.1M |
2021 Q4
0 quarters
|
|
19
Danaher
DHR
$163B
| $15M | 1.72% |
+51,334
| New | +$14.1M |
2021 Q4
0 quarters
|
|
20
Under Armour
UAA
$2.1B
| $14.8M | 1.7% |
697,000
-303,000
| -30% | -$6.88M |
2021 Q3
1 quarter
|
|
21
AbbVie
ABBV
$501B
| $13.4M | 1.54% |
+99,200
| New | +$11.7M |
2021 Q4
0 quarters
|
|
22
Mirion Technologies
MIR
$3.87B
| $13M | 1.49% |
1,238,500
+580,500
| +88% | +$6.23M |
2021 Q3
1 quarter
|
|
23
PUT
Moderna
MRNA
$94.4B
| $12.7M | 1.46% |
+50,000
| New | +$14.6M |
2021 Q4
0 quarters
|
|
24
Bloomin' Brands
BLMN
$850M
| $12.3M | 1.41% |
+585,000
| New | +$12.3M |
2021 Q4
0 quarters
|
|
25
Apollo Global Management
APO
$66.1B
| $11.2M | 1.29% |
+155,000
| New | +$11.2M |
2021 Q4
0 quarters
|
|
Similar funds
PHP
ACM
FM
PAMI
SI
ZI
RIA
PC
Kingdon Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Kingdon Capital Management held 97 positions worth $870M, up 5.8% from $822M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Kingdon Capital Management deployed $72.9M of net new capital in Q4 2021, opening 35 new positions and adding to 13 existing holdings. Its largest new stake was RenaissanceRe: 175,000 shares worth $29.6M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $11M trimmed.
- Kingdon Capital Management's largest Q4 2021 buy was RenaissanceRe: 175,000 shares worth $29.6M.
- Kingdon Capital Management added most to Humana in Q4 2021, an estimated $10.3M increase.
- Kingdon Capital Management's biggest Q4 2021 reduction was Walt Disney, cutting an estimated $11M.
- Kingdon Capital Management fully exited Lithia Motors in Q4 2021, selling an estimated $24.9M.
- Kingdon Capital Management's ten largest holdings make up 42% of its $870M portfolio in Q4 2021.
- Kingdon Capital Management opened 35 new positions and closed 20 in Q4 2021.
- Kingdon Capital Management's portfolio value rose 5.8% quarter-over-quarter to $870M.
Based on Kingdon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.